Results 261 to 270 of about 1,396,034 (289)
Some of the next articles are maybe not open access.
Urologic Clinics of North America, 1989
In reviewing the experience of a number of authors and investigators, it is clear that early diagnosis of adrenocortical carcinoma is essential for cure. Of all the modalities of therapy currently available, surgical resection holds the most promise for cure or prolonged survival.
J I, Barzilay, A G, Pazianos
openaire +2 more sources
In reviewing the experience of a number of authors and investigators, it is clear that early diagnosis of adrenocortical carcinoma is essential for cure. Of all the modalities of therapy currently available, surgical resection holds the most promise for cure or prolonged survival.
J I, Barzilay, A G, Pazianos
openaire +2 more sources
World Journal of Urology, 1999
Abstract Adrenocortical carcinoma is a rare tumor with an annual incidence of between 0.5 and 2 cases per million (Brennan 1987; National Cancer Institute 1975). This is in contrast to the incidence of adenomas of the adrenal gland yielding a relatively frequent finding of an ‘ incidentaloma’ in patients having cross- sectional imaging ...
R D, Schulick, M F, Brennan
openaire +2 more sources
Abstract Adrenocortical carcinoma is a rare tumor with an annual incidence of between 0.5 and 2 cases per million (Brennan 1987; National Cancer Institute 1975). This is in contrast to the incidence of adenomas of the adrenal gland yielding a relatively frequent finding of an ‘ incidentaloma’ in patients having cross- sectional imaging ...
R D, Schulick, M F, Brennan
openaire +2 more sources
Oncocytic adrenocortical carcinoma
Urology, 2004Oncocytic adrenocortical carcinoma is rare. To our knowledge, only 6 cases have been previously reported. We describe an additional case of oncocytic adrenocortical carcinoma. A 54-year-old man presented with a right subcostal mass. Computed tomography demonstrated a massive tumor in the right abdomen.
Kazushi, Tanaka +7 more
openaire +2 more sources
Large Adrenocortical Carcinoma
Journal of the National Medical Association, 2009Adrenal cortical carcinomas (ACCs) are rare, highly malignant tumors that carry a poor prognosis. The large size and possibility of adherence to adjacent structures can make these tumors difficult to excise. We present a patient who underwent successful resection of a massive 19-cm, nonfunctional ACC, which encased the right kidney.
Kristian L, Brown, Daniel, Bacal
openaire +2 more sources
Oncocytic adrenocortical carcinoma
Annals of Diagnostic Pathology, 2010Only 17 cases of oncocytic adrenocortical carcinoma have been reported in the English literature. Here, we report an incidental case of oncocytic adrenocortical carcinoma. The patient was a 69-year-old man with the chief complaint of abdominal pain. Abdominal computed tomography revealed a left adrenal tumor. No hormonal symptoms were observed.
Hiroya, Ohtake +6 more
openaire +2 more sources
Advances in Anatomic Pathology, 2014
Adrenocortical carcinoma is a rare endocrine tumor with a poor prognosis. These tumors can be diagnostically challenging, and diagnostic algorithms and criteria continue to be suggested. Myxoid and oncocytic variants are important to recognize to not confuse with other tumors.
Lori A, Erickson +2 more
openaire +2 more sources
Adrenocortical carcinoma is a rare endocrine tumor with a poor prognosis. These tumors can be diagnostically challenging, and diagnostic algorithms and criteria continue to be suggested. Myxoid and oncocytic variants are important to recognize to not confuse with other tumors.
Lori A, Erickson +2 more
openaire +2 more sources
Open vs laparoscopic adrenalectomy for localized adrenocortical carcinoma
Clinical Endocrinology, 2020The purpose of the study was to compare the long‐term outcomes of patients with localized adrenocortical carcinoma (ACC) subjected to open vs laparoscopic surgery.
D. Kaštelan +12 more
semanticscholar +1 more source
Clinical Endocrinology, 2020
Mitotane is used in the treatment of adrenocortical carcinoma (ACC). Metabolic and hormonal side effects of mitotane, the effect of subsequent treatment with statins and hormones and the effects of discontinuation of mitotane were assessed.
Malene Elbaek Vikner +3 more
semanticscholar +1 more source
Mitotane is used in the treatment of adrenocortical carcinoma (ACC). Metabolic and hormonal side effects of mitotane, the effect of subsequent treatment with statins and hormones and the effects of discontinuation of mitotane were assessed.
Malene Elbaek Vikner +3 more
semanticscholar +1 more source
Adrenocortical carcinoma: current treatment options
Current Opinion in Oncology, 2020Purpose of review In this article, we focus on the current and future treatment options for adrenocortical carcinoma (ACC). Recent findings Radical surgery remains the only curative treatment for ACC.
G. De Filpo, M. Mannelli, L. Canu
semanticscholar +1 more source
Endocrinology and Metabolism Clinics of North America, 2015
Recent developments in the treatment of adrenocortical carcinoma (ACC) include diagnostic and prognostic risk stratification algorithms, increasing evidence of the impact of historical therapies on overall survival, and emerging targets from integrated epigenomic and genomic analyses.
openaire +2 more sources
Recent developments in the treatment of adrenocortical carcinoma (ACC) include diagnostic and prognostic risk stratification algorithms, increasing evidence of the impact of historical therapies on overall survival, and emerging targets from integrated epigenomic and genomic analyses.
openaire +2 more sources